Human stem cell derived beta-like cells engineered to present PD-L1 improve transplant survival in NOD mice carrying human HLA class I is a research paper published in Frontiers in Endocrinology (2022). On theSindex it has a DataRank of 0.483. It has been cited 24 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.483
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Juvenile Diabetes Research Foundation United States of America
Grant: 2-SRA-2019-781-S-B
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01DK132387
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01DK120444
Human Islet Research Network
Grant: UC24 DK104162
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: P30 DK116073
National Institutes of Health
Grant: 5P30DK116073-03
UC Denver Diabetes Research Center
National Institutes of Health
Grant: 5R01DK132387-03
Local immune modulation for beta cell replacement therapy in type 1 diabetes
National Institutes of Health
Grant: 5R01DK120444-03
Improving human pluripotent stem cell derived beta cell transplantation using genetic lineage tracing.
FWCI
4.22
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals